Answer
Dasatinib should be administered cautiously in patients with hepatic impairment because of limitations of the single-dose pharmacokinetic study, although patients with mild, moderate or severe impairment may receive the recommended starting dose.
Sources for this answer
- Sprycel 20mg, 50mg, 80mg, 100mg and 140mg Film Coated TabletsBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 21Document updated
Sources checked